1. MiR-422a targets MAPKK6 and regulates cell growth and apoptosis in colorectal cancer cells
- Author
-
Shao-Jun Sun, Peng Li, Zhaoxi Lu, Yan-Qiang Zhang, Qing-Min Li, and Shuntao Liu
- Subjects
Male ,0301 basic medicine ,MAPK/ERK pathway ,Colorectal cancer ,p38 mitogen-activated protein kinases ,Cell ,Mice, Nude ,Apoptosis ,MAP Kinase Kinase 6 ,Biology ,p38 Mitogen-Activated Protein Kinases ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Cell Line, Tumor ,microRNA ,medicine ,Animals ,Humans ,Genes, Tumor Suppressor ,Cell Proliferation ,Pharmacology ,Mice, Inbred BALB C ,Cell growth ,General Medicine ,Transfection ,Middle Aged ,HCT116 Cells ,Prognosis ,medicine.disease ,MicroRNAs ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Cancer research ,Female ,Colorectal Neoplasms - Abstract
The important role of miR-422a in tumor has been reported in several studies. Recent research discovered that the expression of miR-422a was significantly decreased in colorectal cancer tissues, providing miR-422a as a tumor suppressor in CRC. However, the concrete mechanism of miR-422a regulating CRC cell is still unclear. In this study, we demonstrated that miR-422a could inhibit CRC cell growth and promote cell apoptosis via in vitro analyses. Moreover, computational methods were adopted to identify the targets of miR-422a. We found MAPKK6 was the direct target of miR-422a. Consequently, we further elucidated that miR-422a inhibited CRC cell growth and induced cell apoptosis by inhibiting p38/MAPK pathway. Besides that, we established the tumor xenograft model using nude mice and the inhibitory effects on tumor volumes and weights by miR-422a mimic transfection were also detected. Taken together, these findings demonstrated miR-422a exerted anti-cancer activities on CRC, which could be potentially used for CRC prognosis prediction and treatment.
- Published
- 2018
- Full Text
- View/download PDF